rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Income
Operating income 805.60 813.56 831.81 728.29 571.00
Expenses
Material consumed 311.96 297.98 307.86 234.28 183.64
Manufacturing expenses - 7.37 7.72 8.27 8.30
Personnel expenses 230.21 219.54 216.70 197.40 153.53
Selling expenses - - - - -
Adminstrative expenses 177.26 153.20 178.83 217.04 179.24
Expenses capitalised - - - - -
Cost of sales 719.43 678.09 711.11 656.99 524.71
Operating profit 86.17 135.47 120.70 71.30 46.29
Other recurring income 14.76 12.84 12.99 16.29 12.25
Adjusted PBDIT 100.93 148.31 133.69 87.59 58.54
Financial expenses 0.95 1.09 1.14 - -
Depreciation 16.95 20.13 18.58 14.92 14.74
Other write offs - - - - -
Adjusted PBT 83.04 127.09 113.97 72.67 43.80
Tax charges 21.44 33.79 41.76 18.22 17.89
Adjusted PAT 61.59 93.30 72.21 54.45 25.91
Non recurring items - 3.43 -4.92 -0.60 -2.28
Other non cash adjustments - - - - -
Reported net profit 61.59 96.73 67.29 53.85 23.63
Earnigs before appropriation 61.59 329.10 235.38 168.22 114.37
Equity dividend - 5.00 1.99 - -
Preference dividend - - - - -
Dividend tax - - 0.51 - -
Retained earnings 61.59 324.10 232.88 168.22 114.37

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close